The Latest Breaking News from Ziyad AlAly

For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.

Harlan Krumholz, a cardiologist at the Yale School of Medicine, says he worries about two kinds of long COVID. There’s the obvious version where people suffer prolonged virus symptoms like fatigue, and a stealthier version in which people recover yet carry an added risk of blood clots and strokes.

They argue the threat posed by COVID has lessened because of preexisting immunity and access to treatment. Plus, some deaths may be incorrectly blamed on COVID. Others caution it's too soon to tell.

Rates of anxiety and depression have decreased since first year of the pandemic but there still aren’t enough therapists

The latest COVID-19 surge is waning — but long COVID will be the next public health crisis

LOS ANGELES — Emerging evidence suggests that catching the coronavirus a second time can heighten long-term health risks, a worrisome development as the circulation of increasingly contagious omicron subvariants leads to greater numbers of Californians being reinfected.

Initially, enduring COVID had one redeeming quality: It gave you some short-term immunity from getting infected again.

LOS ANGELES — As highly infectious omicron subvariants continue to fuel a new coronavirus wave, there is growing concern about long COVID, in which symptoms or increased risk of illness can persist for months or even years.

FORT LAUDERDALE, Fla. — Initially, enduring COVID had one redeeming quality: It gave you some short-term immunity from getting infected again.